December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

141.13 -3.68 (-2.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
36 37 Next >
News headline image
Illumina Unusual Options Activity ↗
 
Via Benzinga
News headline image
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics ↗
This is a classic matchup of a grizzled top dog against a scrappy competitor. 
Via The Motley Fool
News headline image
Why Illumina Fell 11.6% in April ↗
The gene-sequencing company reported weaker results while the Federal Trade Commission has ordered it to divest its Grail acquisition. 
Via The Motley Fool
News headline image
Here's How Much You Would Have Made Owning Illumina Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Will Forced Divesture Of Grail Boost Illumina Shareholder Value?
Regulators may force Illumina to divest Grail, which it acquired in 2021. Carl Icahn is also calling for a divestiture. The move could benefit shareholders. 
Via MarketBeat
News headline image
7 Stocks Poised for a Major Breakout in May 2023 ↗
These best breakout stocks are set for an impressive rebound ahead as the stock market starts picking up the pace again 
Via InvestorPlace
News headline image
Illumina Unusual Options Activity ↗
 
Via Benzinga
News headline image
A Look Into Illumina's Debt ↗
 
Via Benzinga
News headline image
FDA Warns Cybersecurity Vulnerability For Illumina Sequencers ↗
The FDA issued a letter noting that nearly the 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Illumina Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review ↗
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
News headline image
Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings: Top Stories For Today ↗
Benzinga 
Via Benzinga
News headline image
3 Telemedicine Stocks to Watch as Healthcare Goes Digital ↗
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector 
Via InvestorPlace
News headline image
Baird Maintains Neutral Rating for Illumina: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Illumina's Q1 Revenue Drop, Dwindling Margins: Outlines Cost Cutting Plans With $100M Savings ↗
 
Via Benzinga
News headline image
Illumina Narrowly Squeaks Out First-Quarter Beat As Grail Battle Continues ↗
The company is fighting both regulators and its own shareholders to retain Grail. 
Via Investor's Business Daily
Realtimecampaign.com Discusses Some of the Many Benefits of Genotyping
Via Get News
News headline image
This Is What Whales Are Betting On Illumina ↗
 
Via Benzinga
News headline image
A Preview Of Illumina's Earnings ↗
 
Via Benzinga
News headline image
Looking At Illumina's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
Profit from the Artificial Intelligence Boom with These 7 AI ETFs ↗
The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs. 
Via InvestorPlace
News headline image
Here's Why You Shouldn't Buy the Dip With Illumina Stock ↗
There aren't many factors driving its growth at the moment. 
Via The Motley Fool
News headline image
What Does Illumina's Debt Look Like? ↗
 
Via Benzinga
News headline image
Is There Any Hope for Illumina Stock? ↗
Being in trouble with regulators in two major markets sure won't help anything. 
Via The Motley Fool
News headline image
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market ↗
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at... 
Via Talk Markets
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow ↗
A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global... 
Via Benzinga
News headline image
The 3 Best Millionaire-Maker Stocks to Buy for April 2023 ↗
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire. 
Via InvestorPlace
News headline image
Illumina Unusual Options Activity ↗
 
Via Benzinga
News headline image
FTC Orders Illumina To Divest Grail, Mounts Pressure On Company Amid Proxy Fight With Icahn ↗
 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.